Curated News
By: NewsRamp Editorial Staff
November 16, 2026
CCHR Demands Oversight of Elderly Drugging and Electroshock in Nursing Homes
TLDR
- CCHR demands stricter oversight of nursing home antipsychotic and electroshock use, creating an opening for advocates to push reforms and challenge facilities.
- Federal reports show antipsychotic use rose 52 percent from 2015 to 2024, with OIG finding failures in pharmacist review and medical director oversight.
- CCHR urges ending forced psychiatric treatment and electroshock for elderly patients, advocating safer alternatives to protect vulnerable seniors from harm.
- Electroshock sends up to 460 volts through the brain, and a 1993 study found 27 percent of patients 80 and older died within a year after treatment.
Impact - Why it Matters
This news matters because it exposes a hidden crisis in elder care: the widespread use of antipsychotics and electroshock on vulnerable seniors, often without consent or proper safeguards. With antipsychotic use among the elderly rising sharply and federal watchdogs confirming that nursing homes frequently fail to follow required non-drug interventions, families with loved ones in long-term care face urgent questions about safety. The documented risks—including increased mortality, stroke, and cognitive decline—mean that current practices may be shortening lives and diminishing quality of life for millions. As the population ages, the need for strict oversight and safer alternatives becomes ever more critical. Readers should be aware that they can report abuse and advocate for policy changes to protect this vulnerable population.
Summary
A federal watchdog report has found that nursing homes continue to use antipsychotic drugs as chemical restraints on elderly residents, often without first attempting required non-drug interventions. According to national data, antipsychotic use among adults aged 65 and older increased nearly 52% between 2015 and 2024, while long-term use rose almost 65%. The Citizens Commission on Human Rights (CCHR) International is demanding greatly increased oversight of the drugging of the elderly and the administration of electroshock treatment, a practice it says should be prohibited. These recommendations align with a federal assessment that antipsychotic use among nursing home residents remains concerning despite a decade of efforts to reduce it. The drugs carry severe side effects for elderly people with dementia; the Food and Drug Administration (FDA) issued a boxed warning against their use in this population because of the increased risk of death. Studies link newer antipsychotics in older adults with dementia to sharply higher risks of stroke, heart failure, accelerated cognitive decline, and bone fractures from falls.
The Health and Human Services Office of Inspector General (OIG) has flagged the sedative effect of these drugs, raising concerns that nursing homes may use them to control residents' behavior for the benefit of staff. Investigators found that some medical directors failed to prevent inappropriate use, nursing home pharmacists did not identify medical concerns or recommend dose reductions, and inadequate policies undermined safeguards meant to protect residents. This persists even though the Centers for Medicare & Medicaid Services has taken steps to discourage the practice. Lori Smetanka, executive director of the National Consumer Voice for Quality Long-Term Care, notes: "Instead of getting to the root problem and addressing the problem, we're quieting them down. And then that's what leads to significant problems with their health and well-being."
The risk extends further. Nearly every person diagnosed with dementia—up to an estimated 97%—will eventually experience changes in mood, perception or behavior, placing them at risk of both psychotropic drugs and electroconvulsive therapy (ECT), also known as "electroshock." According to The New York Times, elderly persons have been electroshocked after they are already prescribed "so many other drugs that they cannot safely add a powerful psychiatric drug." A psychiatrist writing in Ethical Human Psychology and Psychiatry warned that "ECT is especially devastating to the vulnerable brain and body of the elderly." Medicare data show that in 2018, 20,436 beneficiaries received nearly 116,000 ECT treatments, with $31 million paid for the 2016–2018 period. Cognitive harm is documented: a clinical neuropsychology study of 62 non-demented elderly depressed patients found that 40% showed significant individual-level decline within one week after ECT. Mortality risks are also elevated; in a 1993 Brown University study of patients 80 and older, 27% of those given ECT were dead within one year compared with 4% of a similar, untreated group. Jan Eastgate, president of CCHR International, states: "The cumulative picture is one of institutionalization that too often relies on drugs, ECT, and restraints rather than addressing root causes. This is the legacy of the widespread introduction of psychiatric treatment into the care of the elderly and requires intense oversight, an end to forced psychiatric treatment, and the adoption of safer alternatives." CCHR encourages reporting psychiatric abuse of the elderly and advises individuals to contact their Congressional and state representatives about the abuse and demand strict enforcement of non-drug interventions and a prohibition on electroshock for all. CCHR is a mental health watchdog established in 1969 by the Church of Scientology and psychiatrist Thomas Szasz, which investigates and exposes psychiatric abuses to protect vulnerable populations from harmful treatments.
Source Statement
This curated news summary relied on content distributed by 24-7 Press Release. Read the original source here, CCHR Demands Oversight of Elderly Drugging and Electroshock in Nursing Homes
